Scarica l'app Stockscreener
79.47
3.46%
2.66
Dopo l'orario di chiusura:
80.00
0.53
+0.67%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CORT Giù?
Forum
Previsione
Precedente Chiudi:
$76.81
Aprire:
$78.38
Volume 24 ore:
1.21M
Relative Volume:
1.42
Capitalizzazione di mercato:
$8.37B
Reddito:
$628.56M
Utile/perdita netta:
$141.82M
Rapporto P/E:
63.07
EPS:
1.26
Flusso di cassa netto:
$142.60M
1 W Prestazione:
-10.06%
1M Prestazione:
+11.43%
6M Prestazione:
+23.02%
1 anno Prestazione:
+68.12%
Intervallo 1D:
$76.34
$79.58
Intervallo di 1 settimana:
$69.43
$87.54
Portata 52W:
$42.01
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
Nome
Corcept Therapeutics Inc
Settore
Industria
Telefono
650.688.8803
Indirizzo
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Confronta CORT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
79.47 | 7.60B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-11-06 | Aggiornamento | Truist | Hold → Buy |
| 2023-04-11 | Iniziato | SVB Securities | Market Perform |
| 2023-04-04 | Iniziato | Piper Sandler | Overweight |
| 2023-02-15 | Downgrade | Jefferies | Buy → Hold |
| 2022-08-01 | Downgrade | Truist | Buy → Hold |
| 2022-07-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-06-27 | Ripresa | Canaccord Genuity | Buy |
| 2022-02-02 | Iniziato | Canaccord Genuity | Buy |
| 2022-01-28 | Iniziato | Truist | Buy |
| 2020-08-05 | Downgrade | Jefferies | Buy → Hold |
| 2019-09-24 | Iniziato | Jefferies | Buy |
| 2019-09-06 | Iniziato | H.C. Wainwright | Buy |
| 2019-02-04 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | Reiterato | Stifel | Hold |
| 2018-05-31 | Downgrade | Stifel | Buy → Hold |
| 2018-03-09 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | Iniziato | Stifel | Buy |
| 2017-02-02 | Iniziato | Ladenburg Thalmann | Buy |
| 2015-04-21 | Iniziato | FBR Capital | Outperform |
| 2014-01-13 | Downgrade | Stifel | Buy → Hold |
| 2013-08-09 | Downgrade | Janney | Buy → Neutral |
| 2013-08-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | Reiterato | JMP Securities | Mkt Outperform |
| 2010-01-06 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | Iniziato | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | Aggiornamento | Punk, Ziegel & Co | Mkt Perform → Accumulate |
Mostra tutto
Corcept Therapeutics Inc Borsa (CORT) Ultime notizie
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Corcept Therapeutics Incorporat (CORT) Stock forecasts - Yahoo
Analyzing Corcept Stock After 53% Surge and Positive FDA Update in 2025 - Yahoo Finance
Has Corcept Therapeutics Incorporated formed a bullish divergenceMarket Performance Report & Technical Pattern Recognition Alerts - newser.com
Swisher Daniel N Jr sells Corcept Therapeutics (CORT) shares for $192,588 - Investing.com India
Corcept Therapeutics Director Sells 2,200 Shares - TradingView
Corcept insider trades: 2,200 options exercised, sale at $87.54 - Stock Titan
Corcept (CORT) Shares Skyrocket, What You Need To Know - Yahoo Finance
Volume spikes in Corcept Therapeutics Incorporated stock – what they meanJuly 2025 Short Interest & AI Optimized Trade Strategies - newser.com
How Corcept Therapeutics Incorporated stock compares to growth peersJuly 2025 Analyst Calls & Long-Term Growth Stock Strategies - newser.com
How sentiment analysis helps forecast Corcept Therapeutics IncorporatedJuly 2025 Final Week & AI Driven Stock Movement Reports - newser.com
CORT Files MAA for Relacorilant in Platinum-Resistant Ovarian Cancer - Yahoo Finance
Corcept: Transition To New Specialty Pharmacy Well Underway (NASDAQ:CORT) - Seeking Alpha
Corcept seeks European approval of relacorilant for ovarian cancer - Rare Cancer News
Technical analysis overview for Corcept Therapeutics Incorporated stockNew Guidance & High Conviction Investment Ideas - newser.com
Momentum divergence signals in Corcept Therapeutics Incorporated chart2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - newser.com
Is Corcept Therapeutics Incorporated stock positioned well for digital economyJuly 2025 EndofMonth & Reliable Price Action Trade Plans - newser.com
Analyzing Corcept Therapeutics Incorporated with risk reward ratio chartsGlobal Markets & High Win Rate Trade Alerts - newser.com
Corcept Therapeutics (CORT) Seeks EMA Approval for Relacorilant in Cancer Treatment - GuruFocus
Corcept Therapeutics Incorporated Submits Marketing Authorization Application to European Medicines Agency for Relacorilant as A Treatment for Patients with Platinum-Resistant Ovarian Cancer - MarketScreener
Corcept Therapeutics Incterminates distribution agreement with Optime CareSEC filing - MarketScreener
[8-K] – CORCEPT THERAPEUTICS INC (CORT) (CIK 0001088856) | CORT SEC FilingForm 8-K - Stock Titan
CORT ends Optime Care pact; exclusivity ended Sept 15, 2025 - Stock Titan
Corcept Therapeutics Incorporated $CORT Holdings Trimmed by Aberdeen Group plc - MarketBeat
What momentum indicators show for Corcept Therapeutics Incorporated stockQuarterly Market Summary & Risk Controlled Stock Pick Alerts - newser.com
What moving averages say about Corcept Therapeutics Incorporated2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
Corcept Therapeutics (CORT) Stock Analysis: A Promising 82.87% Upside in the Biotech Sector - DirectorsTalk Interviews
Corcept Therapeutics (CORT) Is Down 16.1% After Distribution Shift and Insider Selling—What's Changed - Yahoo Finance
Maryland State Retirement & Pension System Has $2.37 Million Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider William Guyer Sells 20,000 Shares - MarketBeat
Corcept Therapeutics (CORT) Sees Significant Drop of 13.3% - GuruFocus
Why Corcept (CORT) Shares Are Falling Today - The Globe and Mail
3 Profitable Stocks That Concern Us - The Globe and Mail
Corcept Therapeutics (CORT) Shares Drop as Optime Care Ends Dist - GuruFocus
Corcept Therapeutics (CORT) Adjusts Korlym Distribution Strategy - GuruFocus
Corcept Therapeutics (CORT) Shares Drop Amid Market Activity - GuruFocus
CORT insider sale: 2,200 shares planned for 10/10/2025 ($192,588) - Stock Titan
Corcept Therapeutics (CORT) Rating Reiterated as 'Buy' by HC Wai - GuruFocus
Corcept Therapeutics' (CORT) "Hold (C)" Rating Reiterated at Weiss Ratings - MarketBeat
Insider Sell: William Guyer Sells 20,000 Shares of Corcept Thera - GuruFocus
Platinum-Resistant Ovarian Cancer Treatment Market Sees Momentum with Next-Generation Targeted Strategies | DelveInsight - The Malaysian Reserve
CORCEPT insider exercised 20,000 options and sold 20,000 shares - Stock Titan
Corcept Therapeutics Inc Azioni (CORT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Corcept Therapeutics Inc Azioni (CORT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Swisher Daniel N JR | Director |
Oct 10 '25 |
Sale |
87.54 |
2,200 |
192,588 |
0 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):